Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0269 Transporter Info
Gene Name	SLC30A1
Transporter Name	Zinc transporter 1
Gene ID	7779
UniProt ID	Q9Y6M5

Post-Translational Modification of This DT
Overview of SLC30A1 Modification Sites with Functional and Structural Information
Sequence	M G C W G R N R G R L L C M L A L T F M F M V L E V V V S R V T S S L A M L S D S F H M L S D V L A L V V A L V A E R F A R R T H A T Q K N T F G W I R A E V M G A L V N A I F L T G L C F A I L L E A I E R F I E P H E M Q Q P L V V L G V G V A G L L V N V L G L C L F H H H S G F S Q D S G H G H S H G G H G H G H G L P K G P R V K S T R P G S S D I N V A P G E Q G P D Q E E T N T L V A N T S N S N G L K L D P A D P E N P R S G D T V E V Q V N G N L V R E P D H M E L E E D R A G Q L N M R G V F L H V L G D A L G S V I V V V N A L V F Y F S W K G C S E G D F C V N P C F P D P C K A F V E I I N S T H A S V Y E A G P C W V L Y L D P T L C V V M V C I L L Y T T Y P L L K E S A L I L L Q T V P K Q I D I R N L I K E L R N V E G V E E V H E L H V W Q L A G S R I I A T A H I K C E D P T S Y M E V A K T I K D V F H N H G I H A T T I Q P E F A S V G S K S S V V P C E L A C R T Q C A L K Q C C G T L P Q A P S G K D A E K T P A V S I S C L E L S N N L E K K P R R T K A E N I P A V V I E I K N M P N K Q P E S S L
PTM type	X-Acetylation X-Malonylation X-N-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A1			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	444
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC30A1 Lysine 444 has the potential to affect its expression or activity.
Malonylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A1			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	358
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at SLC30A1 Lysine 358 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Accelerating SLC30A1 degradation			[3]
Role of PTM	Degradation via Proteosome
Modified Residue	Asparagine	Modified Location	299
Studied Phenotype	Pancreatic cancer [ICD11: 2C10]
Experimental Material(s)	Human near-haploid (HAP1) cells; and Pancreatic cancer (PANC1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at SLC30A1 Asparagine 299 have been reported to accelerate its degradation.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A1			[4]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	441
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC30A1 Cystine 441 has the potential to affect its expression or activity.
Phosphorylation
Serine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	29
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 29 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A1			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	167
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 167 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	172
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 172 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	173
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 173 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A1			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	197
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 197 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC30A1			[10] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	199
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 199 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC30A1			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	423
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 423 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC30A1			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 426 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC30A1			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	428
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 428 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC30A1			[8] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	429
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 429 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC30A1			[8] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	466
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 466 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC30A1			[9] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	468
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 468 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC30A1			[6] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	473
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 473 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC30A1			[6] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	505
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 505 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC30A1			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	506
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Serine 506 has the potential to affect its expression or activity.
Threonine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A1			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 18 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A1			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	168
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 168 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A1			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	189
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 189 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A1			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	191
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 191 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A1			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	196
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 196 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC30A1			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	415
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 415 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC30A1			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	416
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 416 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC30A1			[8] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	449
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 449 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC30A1			[8] , [17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	462
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A1 Threonine 462 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A1			[22]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	390
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC30A1 Cystine 390 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A1			[22]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	437
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC30A1 Cystine 437 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A1			[22]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	447
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC30A1 Cystine 447 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A1			[22]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	469
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC30A1 Cystine 469 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A1			[23]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	132
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC30A1 Cystine 132 has the potential to affect its expression or activity.
Ubiquitination
Lysine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing cell surface expression of SLC30A1			[24]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	461
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 461 have been reported to decrease its cell surface expression.
PTM Phenomenon 2	Have the potential to influence SLC30A1			[25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	166
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 166 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A1			[26]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 203 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A1			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	358
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 358 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A1			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	389
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 389 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC30A1			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	401
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 401 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC30A1			[25] , [26]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	404
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 404 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC30A1			[27] , [28]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	427
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 427 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC30A1			[27] , [28]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	444
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 444 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC30A1			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	457
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 457 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC30A1			[25] , [29]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	478
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 478 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC30A1			[29]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	479
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 479 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC30A1			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	484
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 484 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC30A1			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	496
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 496 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC30A1			[25] , [27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	501
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A1 Lysine 501 has the potential to affect its expression or activity.

References
1	Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
2	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
3	Zinc transporter 1 (ZNT1) expression on the cell surface is elaborately controlled by cellular zinc levels. J Biol Chem. 2019 Oct 25;294(43):15686-15697.
4	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
5	Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
6	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
7	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
8	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
9	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
10	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
11	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
12	Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants. Elife. 2016 Sep 30;5:e18296.
13	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
14	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
15	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
16	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
17	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
18	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
19	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
20	Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 Dec 17;80(6):1104-1122.e9.
21	Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J Proteome Res. 2010 Dec 3;9(12):6786-94.
22	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
23	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
24	Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell Biosci. 2021 Apr 17;11(1):75.
25	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
26	Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
27	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.
28	Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020 Feb;27(2):210-220.
29	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence